These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

80 related articles for article (PubMed ID: 24147560)

  • 1. Early impairment in brain metabolism detected by MR spectroscopy antedates structural changes in mouse models of spinocerebellar ataxias.
    Mlynárik V; McKenna MC
    J Neurochem; 2013 Dec; 127(5):578-9. PubMed ID: 24147560
    [No Abstract]   [Full Text] [Related]  

  • 2. Non-invasive detection of neurochemical changes prior to overt pathology in a mouse model of spinocerebellar ataxia type 1.
    Emir UE; Brent Clark H; Vollmers ML; Eberly LE; Öz G
    J Neurochem; 2013 Dec; 127(5):660-8. PubMed ID: 24032423
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hereditary ataxia. An unfolded protein.
    Orr HT
    Lancet; 2001 Dec; 358 Suppl():S35. PubMed ID: 11784584
    [No Abstract]   [Full Text] [Related]  

  • 4. Neurodegeneration: a question of balance.
    Thompson LM
    Nature; 2008 Apr; 452(7188):707-8. PubMed ID: 18401401
    [No Abstract]   [Full Text] [Related]  

  • 5. Interaction between mutant ataxin-1 and PQBP-1 affects transcription and cell death.
    Okazawa H; Rich T; Chang A; Lin X; Waragai M; Kajikawa M; Enokido Y; Komuro A; Kato S; Shibata M; Hatanaka H; Mouradian MM; Sudol M; Kanazawa I
    Neuron; 2002 May; 34(5):701-13. PubMed ID: 12062018
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Tissue transglutaminase crosslinks ataxin-1: possible role in SCA1 pathogenesis.
    D'Souza DR; Wei J; Shao Q; Hebert MD; Subramony SH; Vig PJ
    Neurosci Lett; 2006 Nov; 409(1):5-9. PubMed ID: 17045396
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Amino acids in a region of ataxin-1 outside of the polyglutamine tract influence the course of disease in SCA1 transgenic mice.
    Skinner PJ; Vierra-Green CA; Emamian E; Zoghbi HY; Orr HT
    Neuromolecular Med; 2002; 1(1):33-42. PubMed ID: 12025814
    [TBL] [Abstract][Full Text] [Related]  

  • 8. 14-3-3 proteins and spinocerebellar ataxia type 1: from molecular interaction to human neuropathology.
    Umahara T; Uchihara T
    Cerebellum; 2010 Jun; 9(2):183-9. PubMed ID: 20155408
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Down the ataxin-1 track.
    López JC
    Nat Rev Neurosci; 2000 Dec; 1(3):154. PubMed ID: 11257899
    [No Abstract]   [Full Text] [Related]  

  • 10. Clues to the cause of neurodegeneration.
    Evans KL
    Mol Med Today; 2000 Jun; 6(6):219. PubMed ID: 10939840
    [No Abstract]   [Full Text] [Related]  

  • 11. Pigmentary macular dystrophy in spinocerebellar ataxia type 1.
    Saito Y; Matsumura K; Shimizu S; Ichikawa Y; Ochiai K; Goto J; Tsuji S; Shimizu T
    J Neurol Neurosurg Psychiatry; 2006 Nov; 77(11):1293. PubMed ID: 17043301
    [No Abstract]   [Full Text] [Related]  

  • 12. Vascular endothelial growth factor ameliorates the ataxic phenotype in a mouse model of spinocerebellar ataxia type 1.
    Cvetanovic M; Patel JM; Marti HH; Kini AR; Opal P
    Nat Med; 2011 Oct; 17(11):1445-7. PubMed ID: 22001907
    [TBL] [Abstract][Full Text] [Related]  

  • 13. In vivo monitoring of recovery from neurodegeneration in conditional transgenic SCA1 mice.
    Oz G; Vollmers ML; Nelson CD; Shanley R; Eberly LE; Orr HT; Clark HB
    Exp Neurol; 2011 Dec; 232(2):290-8. PubMed ID: 21963649
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Magnetic resonance imaging in spinocerebellar ataxias.
    Döhlinger S; Hauser TK; Borkert J; Luft AR; Schulz JB
    Cerebellum; 2008; 7(2):204-14. PubMed ID: 18418677
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Protein-protein interaction networks in the spinocerebellar ataxias.
    Rubinsztein DC
    Genome Biol; 2006; 7(8):229. PubMed ID: 16904001
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Molecular pathway analysis towards understanding tissue vulnerability in spinocerebellar ataxia type 1.
    Driessen TM; Lee PJ; Lim J
    Elife; 2018 Dec; 7():. PubMed ID: 30507379
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Role of tissue transglutaminase type 2 in calbindin-D28k interaction with ataxin-1.
    Vig PJ; Wei J; Shao Q; Hebert MD; Subramony SH; Sutton LT
    Neurosci Lett; 2007 Jun; 420(1):53-7. PubMed ID: 17442486
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Noninvasive detection of presymptomatic and progressive neurodegeneration in a mouse model of spinocerebellar ataxia type 1.
    Oz G; Nelson CD; Koski DM; Henry PG; Marjanska M; Deelchand DK; Shanley R; Eberly LE; Orr HT; Clark HB
    J Neurosci; 2010 Mar; 30(10):3831-8. PubMed ID: 20220018
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hereditary ataxias.
    Evidente VG; Gwinn-Hardy KA; Caviness JN; Gilman S
    Mayo Clin Proc; 2000 May; 75(5):475-90. PubMed ID: 10807077
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Identification of a novel phosphorylation site in ataxin-1.
    Vierra-Green CA; Orr HT; Zoghbi HY; Ferrington DA
    Biochim Biophys Acta; 2005 May; 1744(1):11-8. PubMed ID: 15878393
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.